Ekonomicke aspekty lecby benigni hyperplazie prostaty

Translated title of the contribution: Economic aspects of treatment of benign hyperplasia of the prostate

D. Pacik, H. Logan Holtgrewe

Research output: Contribution to journalArticle

Abstract

BPH is a relatively frequent disease and the costs associated with its treatment contribute in a major way to the costs of treatment of urological patients. Alternative medicamentous and less invasive therapeutic methods led to a decline in the rising number of prostatectomies but did not lead to the assumed decline of costs, on the contrary. The question remains how to rationalise to a maximum extent these costs which should be met from public resources, in particular in this disease which usually does not threaten the patient's health nor life. Allocation of constant resources from the gross national product to health services is an important problem also in conjunction with the diagnosis and treatment of BPH.

Original languageCzech
Pages (from-to)178-181
Number of pages4
JournalPrakticky Lekar
Volume79
Issue number3
StatePublished - 1999
Externally publishedYes

Fingerprint

Hyperplasia
Prostate
Economics
Gross Domestic Product
Costs and Cost Analysis
Cost of Illness
Resource Allocation
Prostatectomy
Health Care Costs
Health Services
Therapeutics
Health
Pharmaceutical Preparations

Keywords

  • Benign hyperplasia of the prostate
  • Economic aspects
  • Treatment

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pacik, D., & Logan Holtgrewe, H. (1999). Ekonomicke aspekty lecby benigni hyperplazie prostaty. Prakticky Lekar, 79(3), 178-181.

Ekonomicke aspekty lecby benigni hyperplazie prostaty. / Pacik, D.; Logan Holtgrewe, H.

In: Prakticky Lekar, Vol. 79, No. 3, 1999, p. 178-181.

Research output: Contribution to journalArticle

Pacik, D & Logan Holtgrewe, H 1999, 'Ekonomicke aspekty lecby benigni hyperplazie prostaty', Prakticky Lekar, vol. 79, no. 3, pp. 178-181.
Pacik D, Logan Holtgrewe H. Ekonomicke aspekty lecby benigni hyperplazie prostaty. Prakticky Lekar. 1999;79(3):178-181.
Pacik, D. ; Logan Holtgrewe, H. / Ekonomicke aspekty lecby benigni hyperplazie prostaty. In: Prakticky Lekar. 1999 ; Vol. 79, No. 3. pp. 178-181.
@article{78d4f6939aa04987a8676d9c2cbc60b3,
title = "Ekonomicke aspekty lecby benigni hyperplazie prostaty",
abstract = "BPH is a relatively frequent disease and the costs associated with its treatment contribute in a major way to the costs of treatment of urological patients. Alternative medicamentous and less invasive therapeutic methods led to a decline in the rising number of prostatectomies but did not lead to the assumed decline of costs, on the contrary. The question remains how to rationalise to a maximum extent these costs which should be met from public resources, in particular in this disease which usually does not threaten the patient's health nor life. Allocation of constant resources from the gross national product to health services is an important problem also in conjunction with the diagnosis and treatment of BPH.",
keywords = "Benign hyperplasia of the prostate, Economic aspects, Treatment",
author = "D. Pacik and {Logan Holtgrewe}, H.",
year = "1999",
language = "Czech",
volume = "79",
pages = "178--181",
journal = "Prakticky Lekar",
issn = "0032-6739",
publisher = "Czech Medical Association J.E. Purkyne",
number = "3",

}

TY - JOUR

T1 - Ekonomicke aspekty lecby benigni hyperplazie prostaty

AU - Pacik, D.

AU - Logan Holtgrewe, H.

PY - 1999

Y1 - 1999

N2 - BPH is a relatively frequent disease and the costs associated with its treatment contribute in a major way to the costs of treatment of urological patients. Alternative medicamentous and less invasive therapeutic methods led to a decline in the rising number of prostatectomies but did not lead to the assumed decline of costs, on the contrary. The question remains how to rationalise to a maximum extent these costs which should be met from public resources, in particular in this disease which usually does not threaten the patient's health nor life. Allocation of constant resources from the gross national product to health services is an important problem also in conjunction with the diagnosis and treatment of BPH.

AB - BPH is a relatively frequent disease and the costs associated with its treatment contribute in a major way to the costs of treatment of urological patients. Alternative medicamentous and less invasive therapeutic methods led to a decline in the rising number of prostatectomies but did not lead to the assumed decline of costs, on the contrary. The question remains how to rationalise to a maximum extent these costs which should be met from public resources, in particular in this disease which usually does not threaten the patient's health nor life. Allocation of constant resources from the gross national product to health services is an important problem also in conjunction with the diagnosis and treatment of BPH.

KW - Benign hyperplasia of the prostate

KW - Economic aspects

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0033003348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033003348&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033003348

VL - 79

SP - 178

EP - 181

JO - Prakticky Lekar

JF - Prakticky Lekar

SN - 0032-6739

IS - 3

ER -